All News

Michael O. Koch, MD, current chair of the Urology Residency Review Committee, discusses how the committee is dealing with important issues regarding the training of urologists.

This article focuses on the potentially dangerous urinary tract factors seen in spinal cord injury patients, with an emphasis on early and continuous treatment.

Three areas in urology currently rely upon the use of prostheses: artificial urinary sphincter for urinary incontinence, penile prosthesis for erectile dysfunction, and testicular prosthesis for congenital or acquired absent testis.

The FDA is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.

A new experimental procedure allows boys with cancer to have a tiny portion of their testis removed and frozen for potential future use, according to results of a recent study.

Some elevated PSA levels in men may be caused by a normally occurring hormone and are not necessarily a predictor of the need for a prostate biopsy, according to results of a recently published study.

Despite recent news reports disparaging prostate cancer testing, early detection of the disease remains in the best interest of the patient, according to an AUA statement clarifying its testing recommendations.

Unless Congress takes action, physicians paid under the Medicare fee schedule face another significant pay cut in 2010.

Roger Sur, MD, has been recruited by the University of California, San Diego Medical Center to launch a comprehensive kidney stone treatment center. The center is dedicated to the medical prevention, advanced surgical treatment, and research of kidney stone disease.

Depression, anxiety disorders, and sexual trauma appear to be risk factors in lower urinary tract symptoms such as incontinence and overactive bladder, according to a recent study.

Legislation that would have repealed the controversial Medicare physician payment formula has been blocked by Senate Republicans and Democrats, who expressed worries about its cost.

Recent changes in credit card laws will likely affect everyone in ways both positive and negative.

In part one of this series, Drs. Neil H. Baum and Robert A. Dowling discuss the basics of shooting a patient education video.

Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.

Educate your patients about erectile dysfunction with a free, customizable handout.

Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.

In this podcast, Dr. Phil Hanno interviews Dr. Michael Chancellor on the potential role of botulinum toxin in urology.

Cardiometabolic disorders and urologic disease represent a "perfect storm" of ailments, according to Kevin T. McVary, MD, who discusses the urologist's role in management.

Alpha-blockers, tricyclic antidepressants, or both can improve compliance, lower pressures at bladder capacity, and improve reflux, incontinence, and detrusor overactivity in neurogenic bladder patients.

Robotic prostatectomy in morbidly obese men is feasible, reasonably safe, and appears to provide oncologic control comparable to that achieved in a normal weight population.

Benign PSA, measured in serum with a proprietary automated assay, improves prostate cancer detection when it is incorporated into an artificial neural network.

In this interview, Michael B. Chancellor, MD, discusses using botulinum toxin for treating overactive bladder, BPH, interstitial cystitis, and other conditions.

Botulinum toxin A is proving to be valuable for relief of interstitial cystitis.

New urology products and services from Roche, Accuray Inc., American Medical Systems, Boston Scientific, Primal Pictures, Life-Tech, and Mpathy Medical.

Most do-it-yourself videos require a minimum of tweaking and editing before they're ready to be uploaded to the Internet.

A new study has found that between 3.4 and 7.9 million American women age 18 and over have symptoms consistent with IC/PBS.

Nerve growth factor levels in urine could prove a useful biomarker for interstitial cystitis/painful bladder syndrome and neurogenic overactive bladder.